{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:10:42Z","timestamp":1780081842925,"version":"3.54.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.chest.2017.10.033","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T21:02:01Z","timestamp":1511643721000},"page":"1424-1431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Autoimmunity and COPD"],"prefix":"10.1016","volume":"153","author":[{"given":"Gaetano","family":"Caramori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Mumby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Girbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2006.10.009","article-title":"Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs?","volume":"108","author":"Blum","year":"2007","journal-title":"Immunol Lett"},{"issue":"12","key":"10.1016\/j.chest.2017.10.033_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.it.2007.08.009","article-title":"Do most lymphocytes in humans really reside in the gut?","volume":"28","author":"Ganusov","year":"2007","journal-title":"Trends Immunol"},{"issue":"7","key":"10.1016\/j.chest.2017.10.033_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00184787","article-title":"Distribution of lymphocyte subsets and natural killer cells in the human body","volume":"70","author":"Westermann","year":"1992","journal-title":"Clin Investig"},{"issue":"2","key":"10.1016\/j.chest.2017.10.033_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.immuni.2016.07.007","article-title":"A\u00a0high-dimensional atlas of human T\u00a0cell diversity reveals tissue-specific trafficking and cytokine signatures","volume":"45","author":"Wong","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib5","first-page":"1","article-title":"\u03b3\u03b4 T\u00a0cells and B cells","volume":"134","author":"Born","year":"2017","journal-title":"Adv Immunol"},{"issue":"4","key":"10.1016\/j.chest.2017.10.033_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1189\/jlb.3A0815-359R","article-title":"Depletion of CD4+ CD25+ regulatory T\u00a0cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-\/- mice","volume":"100","author":"Ghosh","year":"2016","journal-title":"J\u00a0Leukoc Biol"},{"issue":"2","key":"10.1016\/j.chest.2017.10.033_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/1348-0421.12471","article-title":"The contrasting roles of Th17 immunity in human health and disease","volume":"61","author":"Hoe","year":"2017","journal-title":"Microbiol Immunol"},{"issue":"7","key":"10.1016\/j.chest.2017.10.033_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.chest.2017.10.033_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","article-title":"COPD immunopathology","volume":"38","author":"Caramori","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.chest.2017.10.033_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/physrev.00025.2015","article-title":"The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease","volume":"97","author":"Hogg","year":"2017","journal-title":"Physiol Rev"},{"issue":"23","key":"10.1016\/j.chest.2017.10.033_bib11","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic aspects of chronic obstructive pulmonary disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib12","first-page":"354","article-title":"Antibodies to human lung in patients with obstructive emphysema and pulmonary tuberculosis","volume":"83","author":"Hennes","year":"1961","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"10.1016\/j.chest.2017.10.033_bib13","doi-asserted-by":"crossref","first-page":"L692","DOI":"10.1152\/ajplung.00092.2014","article-title":"Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD","volume":"307","author":"John-Schuster","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib14","first-page":"198","article-title":"Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease","volume":"7","author":"Lobo","year":"2016","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.chest.2017.10.033_bib15","first-page":"1101","article-title":"Antibodies of IgG, IgA and IgM against human bronchial epithelial cell in patients with chronic obstructive pulmonary disease","volume":"62","author":"Cheng","year":"2016","journal-title":"Clin Lab"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cei.12565","article-title":"Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease","volume":"180","author":"Daffa","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.chest.2017.10.033_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1164\/rccm.200701-014OC","article-title":"Autoantibodies in patients with chronic obstructive pulmonary disease","volume":"177","author":"Feghali-Bostwick","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2017.10.033_bib18","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1038\/cti.2016.57","article-title":"Autoantibodies against CD80 in patients with COPD","volume":"5","author":"Luo","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arcmed.2017.01.007","article-title":"Increased circulating autoantibodies levels of IgG, IgA, IgM against cytokeratin 18 and cytokeratin 19 in chronic obstructive pulmonary disease","volume":"48","author":"Xiong","year":"2017","journal-title":"Arch Med Res"},{"issue":"8","key":"10.1016\/j.chest.2017.10.033_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/rccm.201001-0029OC","article-title":"Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease","volume":"183","author":"N\u00fa\u00f1ez","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2017.10.033_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1164\/rccm.201010-1605OC","article-title":"Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease","volume":"184","author":"Kirkham","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib22","first-page":"18","article-title":"C1q binding activity in the sera of patients with chronic lung diseases","volume":"45","author":"Cooper","year":"1981","journal-title":"Clin Exp Immunol"},{"issue":"17","key":"10.1016\/j.chest.2017.10.033_bib23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","article-title":"Overexpression of the cytokine BAFF and autoimmunity risk","volume":"376","author":"Steri","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2017.10.033_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.201501-0107OC","article-title":"B\u00a0cell-activating factor. An orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease","volume":"192","author":"Polverino","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2017.10.033_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/rccm.201501-0103OC","article-title":"Role of B cell-activating factor in chronic obstructive pulmonary disease","volume":"192","author":"Seys","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.chest.2017.10.033_bib26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1042\/CS20160487","article-title":"Cellular and molecular mechanisms of asthma and COPD","volume":"131","author":"Barnes","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.chest.2017.10.033_bib27","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1164\/rccm.201410-1861OC","article-title":"IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis","volume":"191","author":"Roos","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.chest.2017.10.033_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201504-0779OC","article-title":"Microbiota promotes chronic pulmonary inflammation by enhancing IL-17A and autoantibodies","volume":"193","author":"Yadava","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib30","doi-asserted-by":"crossref","first-page":"1602006","DOI":"10.1183\/13993003.02006-2016","article-title":"Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression","volume":"49","author":"Di Stefano","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1183\/09031936.04.00080303","article-title":"STAT-4 activation in smokers and patients with COPD","volume":"24","author":"Di Stefano","year":"2004","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/09031936.04.00043104","article-title":"Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease","volume":"24","author":"Cosio","year":"2004","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2017.10.033_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1165\/rcmb.2004-0239OC","article-title":"Characterization of the interstitial lung and peripheral blood T\u00a0cell receptor repertoire in cigarette smokers","volume":"32","author":"Korn","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.200410-1332OC","article-title":"Oligoclonal CD4+ T\u00a0cells in the lungs of patients with severe emphysema","volume":"172","author":"Sullivan","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2017.10.033_bib35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1164\/rccm.200910-1485OC","article-title":"Chronic cigarette smoke exposure generates pathogenic T\u00a0cells capable of driving COPD-like disease in Rag2-\/- mice","volume":"181","author":"Motz","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib36","first-page":"617","article-title":"Steroid resistant CD8+CD28null NKT-like pro-inflammatory cytotoxic cells in chronic obstructive pulmonary disease","volume":"7","author":"Hodge","year":"2016","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.chest.2017.10.033_bib37","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.4049\/jimmunol.181.11.8036","article-title":"Persistence of lung CD8 T\u00a0cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema","volume":"181","author":"Motz","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00441-016-2567-7","article-title":"Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models","volume":"367","author":"Craig","year":"2017","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.chest.2017.10.033_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trsl.2015.08.004","article-title":"Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease","volume":"167","author":"Durham","year":"2016","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.chest.2017.10.033_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00848-2017","article-title":"Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids","volume":"49","author":"Kunz","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib41","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.201500135","article-title":"Corticosteroid modulation of immunoglobulin expression and B-cell function in COPD","volume":"30","author":"Lee","year":"2016","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib43","doi-asserted-by":"crossref","first-page":"e0121257","DOI":"10.1371\/journal.pone.0121257","article-title":"Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib44","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00518.2016","article-title":"Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases","volume":"312","author":"Hodge","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.chest.2017.10.033_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14737175.2017.1245616","article-title":"Anti-CD20 monoclonal antibodies in multiple sclerosis","volume":"17","author":"Moreno Torres","year":"2017","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.chest.2017.10.033_bib46","series-title":"Clinical Immunology","first-page":"90","article-title":"B-cell development and differentiation","author":"Schroeder","year":"2013"},{"issue":"12","key":"10.1016\/j.chest.2017.10.033_bib47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.autrev.2015.07.013","article-title":"The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus","volume":"14","author":"D\u00f6rner","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"24","key":"10.1016\/j.chest.2017.10.033_bib48","doi-asserted-by":"crossref","first-page":"e13057","DOI":"10.14814\/phy2.13057","article-title":"Role of BAFF in pulmonary autoantibody responses induced by chronic cigarette smoke exposure in mice","volume":"4","author":"Morissette","year":"2016","journal-title":"Physiol Rep"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1759720X17690474","article-title":"Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness","volume":"9","author":"Guerreiro Castro","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"10.1016\/j.chest.2017.10.033_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jdermsci.2017.06.010","article-title":"IL-17 for therapy","volume":"87","author":"Kurschus","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"issue":"5","key":"10.1016\/j.chest.2017.10.033_bib51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/15412555.2017.1335697","article-title":"A\u00a0randomized, placebo-controlled phase 2 trial of CNTO 6785 in chronic obstructive pulmonary disease","volume":"14","author":"Eich","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.chest.2017.10.033_bib52","doi-asserted-by":"crossref","unstructured":"Boudjelal M, Ruiz-Avendano AM, Colmenarejo G, Senar-Sancho SA, Barnes A, Harrison SA. High throughput screening assay to identify modulators of IL-17 expression [e-pub ahead of print]. Comb Chem High Throughput Screen. https:\/\/doi.org\/10.2174\/1386207320666170602091308, accessed November 6,\u00a02017.","DOI":"10.2174\/1386207320666170602091308"},{"issue":"8","key":"10.1016\/j.chest.2017.10.033_bib53","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369217330465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369217330465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:01:27Z","timestamp":1757923287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369217330465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0012369217330465"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2017.10.033","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity and COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2017.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}